BY ORDER OF THE COMMANDER                             911TH AIRLIFT WING INSTRUCTION
911TH AIRLIFT WING                                                             44-103

                                                                                    2 JULY 2014

                                                                                         Medical

                                                          FORCE HEALTH PRESCRIPTION
                                                        PRODUCTS ANTIDOTES PROGRAM

              COMPLIANCE WITH THIS PUBLICATION IS MANDATORY

ACCESSIBILITY: This publication is available on the e-Publishing website at www.e-
               publihing.af.mil for downloading.

RELEASABILITY: There are no releasability restrictions on this publication.


OPR: 911 AW/ASTS                                                      Certified by: 911 ASTS/CC
                                                                            (Col Sharon Colaizzi)
                                                                                         Pages: 5
Supersedes:    911AWI44-103, 6 June 2003


This instruction implements Air Force Policy Directive 44-1, Medical Operations. It establishes
procedures for ensuring that nerve agent antidotes and pretreatment tablets (p-tabs) are issued to
individuals deploying to areas of a possible chemical warfare agent threat in accordance with
AFI 41-209, Medical Logistics Support. Ensure that all records created as a result of processes
prescribed in this publication are maintained in accordance with Air Force Manual AFMAN 33-
363, Management of Records, and disposed of in accordance with Air Force Records
Information Management System (AFRIMS) Records Disposition Schedule (RDS) located at
https://www.my.af.mil/afrims/afrims/afrims/rds/rds_series.cfm.”           Refer recommended
changes and questions about this publication to the Office of Primary Responsibility (OPR)
using Air Force (AF) Form 847, Recommendation for Change of Publication; route AF Forms
847 from the field through the appropriate functional’s chain of command. See Attachment 1 for
a Glossary of References and Supporting Information.

SUMMARY OF CHANGES

This instruction has been revised and must be completely rewritten. Major changes include the
product title change from Nerve Agent Antidotes and Pretreatment Tablets Issue to Force Health
Prescription Products Antidotes Program, para 1.1 XP has changed to the Unit Deployment
Manager (UDM) and information pertaining to Wright-Patterson AFB has been changed to
reflect the proper unit.
1. Responsibilities:
 2                                                                911AWI44-103 2 JULY 2014


     1.1. 911 Airlift Wing/Unit Deployment Managers (UDM’s) will:
        1.1.1. Notify the 911 MSG/SGPB and the 911 ASTS/SGP by electronic mail
        (911.ASTS.workflow@us.af.mil) within thirty (30) days of receiving official orders
        requiring antidotes for deployers. A brief memorandum will be typed and given to the
        RMU (attach 1). This notification will include the names of the deployers, location, date
        of departure and the total number of deploying personnel.
     1.2. ASTS/SGP:
        1.2.1. Will verify the reporting instructions for the locations and compute the total
        number of personnel deploying and order the necessary Force Health Antidotes from
        WFAFB. The RMU will then use the 88MDSS/SGSM-WRM Request for Force Health
        Prescription Products (FHPPP) Antidotes form to place the order. The order will be
        reviewed by a Public Health Representative and the Commander or Superintendent of
        Medical Services. A cover sheet must be attached to the order containing the receiving
        parties fed-ex account number to ensure that shipment is expedited along with medical
        point of contact information.
            1.2.1.1. The SGP will report the order to the ASTS Senior Medical Air Reserve
            Technician (ART) to ensure that funds have been loaded in the applicable PFMR.
        1.2.2. Ensure nerve agent antidotes and p-tabs for individuals processing by exception
        are secured under lock and key, until issued to deploying individuals.
        1.2.3. Will contact the individual units and dispense the antidotes accordingly to each
        individual deployer. A designated medical representative will update the DD Form 2766
        under medications and in ASIMS (previously PIMR) for each individual located under
        the deployment processing tab for FHPPP. Upon the members return, the correct
        disposition will need to be noted in ASIMS on if the medications were turned back in or
        destroyed. SGP must ensure a complete concise audit trail of issue, use, return and final
        dispositions are made. Any unused antidotes will be returned to the 88th MDSS.
        1.2.4. Obtain approval from Installation deployment Officer (IDO) for approval to issue
        Pyri-dostigmine Bromide (p-tabs).
     1.3. 911 ASTS/SGPM will:
        1.3.1. Brief each individual deploying on the use and precautions of the nerve agent
        antidotes and p-tabs during the medical intelligence briefing prior to deploying.
     1.4. Individual Service Member:
        1.4.1. The deploying member must report to the clinic upon return for proper disposition
        of nerve antidotes. They must report if medications were returned in theater or destroyed.
2. Available Antidotes:
     2.1. Biological Warfare/ Chemical Warfare Antidotes
        2.1.1. Antidote Treatment Nerve Agent Auto Injector (ATNAA).
        2.1.2. Pyridostigmine Tablets.
        2.1.3. Diazepam.
911AWI44-103 2 JULY 2014                                                 3


     2.1.4. Ciproflaxin.
     2.1.5. Doxycycline.
     2.1.6. Reactive Skin Decontamination Lotion Packet.
     2.1.7. Lariam (Mefloquine)
     2.1.8. Chloroquine .
     2.1.9. Malarone (Atovaquone and Proguanil)
     2.1.10. Envelopes, Plastic 5 x 3, 1000’s




                                          JEFFREY S. KOZAK, Col, USAFR
                                          Commander
 4                                                          911AWI44-103 2 JULY 2014


                                      Attachment 1
         GLOSSARY OF REFERENCES AND SUPPORTING INFORMATION

References
AFPD 44-1, Medical Operations, 1 Sept 1999
AFI 41-209, Medical Logistics Support, 13 Aug 2013
AFMAN 33-363, Management of Records, 1 Mar 2008
Adopted Forms
AF Form 847, Recommendation for change of publication, 22 Sep 2009
911AWI44-103 2 JULY 2014                                                                               5


                                           Attachment 2
                                 EXAMPLE MEMORANDUM

                                                                                               Date:


MEMORANDUM FOR 911 ASTS/SGP
FROM: Unit and office symbol(UDM)
SUBJECT: Antidote Request Unit Letter for Force Health Prescription Products (FHPPP)
The (unit) has been tasked with deployer(s) scheduled to deploy in support of (name of
operation) to the location of (location site). According to the reporting instructions dated
(reporting instruction date). The date of departure is (deployment date). We are requesting the
the following individuals be issued antidotes for the above mentioned specified location:


1.     List each deploying member




                                              Signature block of Unit Deployment Manager,
